Clinical Trial Update: AQUALIS:QoL of CLL Patients Treated With Acalabrutinib in France, Retrospective Study Based on Data From PLATON Database

View source ↗

Summary

This entry describes a retrospective study (AQUALIS) to evaluate quality of life in Chronic Lymphocytic Leukemia patients treated with acalabrutinib in France, …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• CALQUENCE (ACALABRUTINIB)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Lymphocytic Leukemia | Status: RECRUITING